Historical record - last NADAC effective date: 8/17/2022
Product Information
METFORMIN HCL 500 MG TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.0148 per EA under NDC 42806031305. Its NADAC has been published 279 times since Apr 19, 2017.
FDA first approved this application on Apr 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Epic Pharma LLCNDC
42806031305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090564FDA Approved
4/22/2010
TE Code
AB
On Market Since
3/13/2017
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 500 MG TABLET has been published 279 times since Apr 19, 2017, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0148 per EA |
|---|---|
| All-time high | $0.0172 (Jun 16, 2021) |
| All-time low | $0.0146 (Jul 20, 2022) |
| Median price | $0.0157 |
| Average price | $0.0158 |
| Largest weekly change | +7.0% (Oct 17, 2018) |
| Weeks tracked | 279 |
| Tracking since | Apr 19, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-8.0%
All
-2.1%
Last surveyed Aug 17, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metformin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by Epic Pharma LLC, is $0.0148 per EA (NDC 42806031305), effective Aug 17, 2022.
How has the price of METFORMIN HCL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has declined 2.1%. It has been tracked across 279 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?
Since Apr 19, 2017, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0146 (Jul 20, 2022) to a high of $0.0172 (Jun 16, 2021), with a median of $0.0157 per EA.
Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 500 MG TABLET, is $0.0145 per EA — about 2% below METFORMIN HCL 500 MG TABLET.
Who manufactures METFORMIN HCL 500 MG TABLET?
METFORMIN HCL 500 MG TABLET (NDC 42806031305) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.